Polewska, K.; Tylicki, P.; Biedunkiewicz, B.; Rucińska, A.; Szydłowska, A.; Kubanek, A.; Rosenberg, I.; Rodak, S.; Ślizień, W.; Renke, M.;
et al. Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project. Medicina 2021, 57, 732.
https://doi.org/10.3390/medicina57070732
AMA Style
Polewska K, Tylicki P, Biedunkiewicz B, Rucińska A, Szydłowska A, Kubanek A, Rosenberg I, Rodak S, Ślizień W, Renke M,
et al. Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project. Medicina. 2021; 57(7):732.
https://doi.org/10.3390/medicina57070732
Chicago/Turabian Style
Polewska, Karolina, Piotr Tylicki, Bogdan Biedunkiewicz, Angelika Rucińska, Aleksandra Szydłowska, Alicja Kubanek, Iwona Rosenberg, Sylwia Rodak, Waldemar Ślizień, Marcin Renke,
and et al. 2021. "Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project" Medicina 57, no. 7: 732.
https://doi.org/10.3390/medicina57070732
APA Style
Polewska, K., Tylicki, P., Biedunkiewicz, B., Rucińska, A., Szydłowska, A., Kubanek, A., Rosenberg, I., Rodak, S., Ślizień, W., Renke, M., Dębska-Ślizień, A., & Tylicki, L.
(2021). Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project. Medicina, 57(7), 732.
https://doi.org/10.3390/medicina57070732
